Concepedia

Publication | Open Access

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

DOIFull Paper Access

105

Citations

37

References

2019

Year

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río, Rosalía Demetrio‐Pablo, E. Beltrán, Juan Sánchez‐Bursón, Marina Mesquida, Alfredo Adán, M.V. Hernández, Marisa Hernández‐Garfella,
Arthritis & Rheumatology

Abstract

Although both IFX and ADA are efficacious in refractory BD-related uveitis, ADA appears to be associated with better outcomes than IFX after 1 year of follow-up.

References

YearCitations

Page 1